Clinical trials
Hemoglobinuria, Paroxysmal trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 11 |
| 2025 | 12 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 12 |
| Active, not recruiting | 9 |
| Not yet recruiting | 7 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wuhan Createrna Science and Technology Co., Ltd | 8 |
| Chengdu Suncadia Medicine Co., Ltd. | 5 |
| Haisco Pharmaceutical Group Co., Ltd. | 5 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Longbio Pharma | 3 |
| Nanjing Chia-tai Tianqing Pharmaceutical | 3 |
| Novartis Pharmaceuticals | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Hoffmann-La Roche | 2 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinuria, Paroxysmal | 49 |
| Anemia | 4 |
| Anemia, Aplastic | 3 |
| Anemia, Hemolytic | 2 |
| Bone Marrow Failure Disorders | 2 |
| Hematologic Diseases | 2 |
| Hemoglobinuria | 2 |
| Proteinuria | 2 |
| Thrombosis | 2 |
| Urination Disorders | 2 |
Trials
Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.